| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 157.13B | 159.58B | 169.94B | 170.54B | 146.29B | 97.80B |
| Gross Profit | 22.98B | 23.71B | 21.79B | 23.26B | 20.90B | 7.48B |
| EBITDA | 10.03B | 10.68B | 8.95B | 9.62B | 9.97B | -1.71B |
| Net Income | 2.10B | 2.36B | -968.00M | 2.19B | 4.07B | -5.53B |
Balance Sheet | ||||||
| Total Assets | 135.89B | 138.67B | 147.07B | 156.41B | 142.96B | 132.32B |
| Cash, Cash Equivalents and Short-Term Investments | 12.65B | 16.16B | 22.24B | 30.62B | 19.97B | 23.00B |
| Total Debt | 49.77B | 52.35B | 57.06B | 66.65B | 49.56B | 51.83B |
| Total Liabilities | 87.50B | 88.81B | 99.24B | 106.72B | 94.31B | 87.54B |
| Stockholders Equity | 41.38B | 42.64B | 41.15B | 43.48B | 42.60B | 38.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.35B | 2.81B | -5.33B | -4.39B | -168.00M |
| Operating Cash Flow | 0.00 | 6.01B | 6.48B | -2.78B | -1.92B | 3.78B |
| Investing Cash Flow | 0.00 | -5.17B | -3.97B | -1.44B | 1.97B | -2.83B |
| Financing Cash Flow | 0.00 | -6.54B | -11.61B | 14.79B | -3.52B | -7.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥350.89B | 12.83 | ― | 3.26% | -7.77% | 58.84% | |
74 Outperform | ¥391.38B | 9.05 | 6.16% | 2.99% | -0.02% | -40.45% | |
73 Outperform | ¥190.56B | 7.83 | 7.36% | 3.42% | -18.72% | -25.26% | |
70 Outperform | ¥104.34B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
67 Neutral | ¥182.59B | 11.58 | 5.06% | 1.80% | 4.10% | 152.90% | |
66 Neutral | ¥27.08B | 21.77 | ― | 4.13% | -2.96% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |